or Try an Advanced Search...

    Technical Analysis for MIRA - MIRA Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 0.66 3.45% 0.02
    MIRA closed up 3.45 percent on Monday, July 1, 2024, on 13 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical MIRA trend table...
    Date Alert Name Type % Chg
    Stochastic Buy Signal Bullish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 3.45%
    Bollinger Band Squeeze Range Contraction 3.45%
    Narrow Range Bar Range Contraction 3.45%
    Lower Bollinger Band Walk Weakness 3.45%
    BB Squeeze + Lower Band Touch Range Contraction 3.45%
    Below Lower BB Weakness 3.45%
    Older End-of-Day Signals for MIRA ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Lower Bollinger Band about 9 hours ago
    Fell Below Previous Day's Low about 9 hours ago
    Up 2% about 9 hours ago
    Up 1% about 9 hours ago
    Fell Below Previous Day's Low 3 days ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    MIRA Chart by TradingView
    Basic chart:

    Profile

    MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog for treating anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - General
    Keywords: Cannabis Euphoriants Chronic Pain Entheogens Cannabinoid Antiemetics Ajulemic Acid Appetite Stimulants

    Is MIRA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 11 MIRA Announces Positive Test Results
    Jun 10 Mira Pharmaceuticals Announces Positive Preclinical Study Results For Its Novel Oral ketamine Analog, Ketamir-2, Paving the Way for IND Submission Later This Year
    May 29 Mira Pharmaceuticals Announces DEA Rules MIRA-55, a Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as a Controlled Substance
    May 21 MIRA Pharmaceuticals in Discussions with Memorial Sloan Kettering to Collaborate on Preclinical Cancer Pain Model Utilizing The Company's Novel Oral Ketamine Analog
    May 20 Dow Falls Over 150 Points; Sohu Posts Q1 Loss
    May 20 Mira Pharmaceuticals Advances Preclinical Trials Towards an IND Submission This Year for Ketamir-2, a Differentiated Oral Ketamine Analog
    Apr 2 MIRA Making Strides Toward Breakthrough Treatment
    Apr 2 Mira Pharmaceuticals Announces Encouraging Preclinical Results Advancing Ketamir-2 Towards Potential Year-End IND Submission
    Mar 21 MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor
    Feb 6 Is MIRA Pharmaceuticals (NASDAQ:MIRA) In A Good Position To Deliver On Growth Plans?
    See more MIRA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.9799
    52 Week Low 0.6309
    Average Volume 132,373
    200-Day Moving Average 1.65
    50-Day Moving Average 0.78
    20-Day Moving Average 0.73
    10-Day Moving Average 0.70
    Average True Range 0.06
    RSI (14) 37.50
    ADX 14.18
    +DI 13.61
    -DI 20.63
    Chandelier Exit (Long, 3 ATRs) 0.73
    Chandelier Exit (Short, 3 ATRs) 0.80
    Upper Bollinger Bands 0.83
    Lower Bollinger Band 0.63
    Percent B (%b) 0.14
    BandWidth 26.94
    MACD Line -0.04
    MACD Signal Line -0.03
    MACD Histogram -0.0062
    Fundamentals Value
    Market Cap 9.74 Million
    Num Shares 14.8 Million
    EPS -0.51
    Price-to-Earnings (P/E) Ratio -1.29
    Price-to-Sales 0.00
    Price-to-Book 1.93
    Dividend 0.00
    Dividend Yield 0.00%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.70
    Resistance 3 (R3) 0.69 0.68 0.69
    Resistance 2 (R2) 0.68 0.67 0.68 0.69
    Resistance 1 (R1) 0.67 0.66 0.67 0.67 0.69
    Pivot Point 0.65 0.65 0.65 0.65 0.65
    Support 1 (S1) 0.64 0.64 0.65 0.65 0.63
    Support 2 (S2) 0.63 0.64 0.63 0.63
    Support 3 (S3) 0.62 0.63 0.63
    Support 4 (S4) 0.62